Picture of UK Houses of Parliament

Leading national thinking on politics, government & public policy through Open Access research

Strathprints makes available scholarly Open Access content by researchers in the School of Government & Public Policy, based within the Faculty of Humanities & Social Sciences.

Research here is 1st in Scotland for research intensity and spans a wide range of domains. The Department of Politics demonstrates expertise in understanding parties, elections and public opinion, with additional emphases on political economy, institutions and international relations. This international angle is reflected in the European Policies Research Centre (EPRC) which conducts comparative research on public policy. Meanwhile, the Centre for Energy Policy provides independent expertise on energy, working across multidisciplinary groups to shape policy for a low carbon economy.

Explore the Open Access research of the School of Government & Public Policy. Or explore all of Strathclyde's Open Access research...

The IHO as actor : the case of cannabis and the Single Convention on Narcotic Drugs 1961

Mills, James H. (2016) The IHO as actor : the case of cannabis and the Single Convention on Narcotic Drugs 1961. Hygiea Internationalis, 13 (1). pp. 95-115. ISSN 1404-4013

Text (Mills-HI-2016-The-IHO-as-actor-the-caseof-cannibis-and-the-single-convention-on-narcotic-drugs-1961)
Final Published Version
License: Creative Commons Attribution-NonCommercial 3.0 logo

Download (2MB)| Preview


    After the Second World War the United Nations (UN) assumed the role of the League of Nations in formulating and operating the international regulatory framework for narcotic drugs. It gathered masses of information from across countries and continents while acting as both a forum and an agent for the emergence of agreed approaches to a heterodox array of substances. This article will examine the story of the inclusion of cannabis in the 1961 Single Convention on Narcotic Drugs. It will argue that in the years after 1945, it was officials at the UN and the WHO that played crucial roles in shaping opinions of the drug and in securing its place in the Convention.